Phosphodiesterase‐4 inhibition reduces proteolysis and atrogenes expression in rat skeletal muscles
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Phosphodiesterase (PDE) inhibition reduces skeletal muscle atrophy, but the underlying molecular mechanism remains unclear. We used microdialysis to investigate the effects of different PDE inhibitors on interstitial tyrosine concentration as well as proteolytic activity and atrogenes expression in isolated rat muscle. Rolipram, a PDE‐4–selective inhibitor, reduced the interstitial tyrosine concentration and rates of muscle protein degradation. The rolipram‐induced muscle cAMP increase was accompanied by a decrease in ubiquitin–proteasome system (UPS) activity and atrogin‐1 mRNA, a ubiquitin‐ligase involved in muscle atrophy. This effect was not associated with Akt phosphorylation but was partially blocked by a protein kinase A inhibitor. Fasting increased atrogin‐1, MuRF‐1 and LC3b expression, and these effects were markedly suppressed by rolipram. Our data suggest that activation of cAMP signaling by PDE‐4 blockade leads to inhibition of UPS activity and atrogenes expression independently of Akt. These findings are important for identifying novel approaches to attenuate muscle atrophy. Muscle Nerve 44: 371–381, 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tanida, I., Ueno, T., & Kominami, E. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-157-4_4 · Cited by 1,785
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“a common program of changes in gene expression that affect around 100 genes, termed atrophyrelated genes or atrogenes.(18,19) Among them, the muscle-specific Ub-ligases (E3s), atrogin-1/MAFbx (muscle atrophy F-box) and MuRF-1 (muscle”
BackgroundZhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489 · cited 1×
“It has been defined that the autophagy/lysosomal and UPS pathways are blocked by common mechanisms involving the insulin-like growth factor (IGF1)/insulin/phosphatidylinositol 3-kinase (PI3K)/ Akt signaling pathway through phosphorylation and nuclear exclusion of Forkhead box class O (Foxo) transcription factors.(25)…”
BackgroundSacheck, J. M., Hyatt, J. K., Raffaello, A., Thomas Jagoe, R., Roy, R. R., Reggie Edgerton, V., Lecker, S. H., & Goldberg, A. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-6604com · Cited by 585 · cited 1×
“a common program of changes in gene expression that affect around 100 genes, termed atrophyrelated genes or atrogenes.(18,19) Among them, the muscle-specific Ub-ligases (E3s), atrogin-1/MAFbx (muscle atrophy F-box) and MuRF-1 (muscle”
BackgroundWhat do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
Jagoe, R. T., & Goldberg, A. L. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200105000-00003 · Cited by 399
Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
Attaix, D., Aurousseau, E., Combaret, L., Kee, A., Larbaud, D., Rallière, C., Souweine, B., Taillandier, D., & Tilignac, T. (1998) · Reproduction Nutrition Development · doi:10.1051/rnd:19980202 · Cited by 109 · cited 1×
“muscle proteolysis, including the major contractile proteins actin and myosin.(16,17) In atrophy conditions, muscle protein is rapidly mobilized through”
Background
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass
Rom, O., & Reznick, A. Z. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.031 · Cited by 256
Lokireddy, S., Kukushkin, N. V., & Goldberg, A. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522332112 · Cited by 228
VerPlank, J. J. S., Lokireddy, S., Zhao, J., & Goldberg, A. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809254116 · Cited by 122
Silveira, W. A., Gonçalves, D. A., Graça, F. A., Andrade-Lopes, A. L., Bergantin, L. B., Zanon, N. M., Godinho, R. O., Kettelhut, I. C., & Navegantes, L. C. C. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01055.2013 · Cited by 47
“105 Indeed, non-selective PDE inhibitors or rolipram, a selective PDE-4 inhibitor, reduce 106 the UPS activity and the Atrogin-1 mRNA in isolated skeletal muscles from normal rats 107 (30) and in cultured muscle cells incubated with dexamethasone (20).”
BackgroundSelf-citation
Metadata
- Authors
- Lira, E. C., Gonçalves, D. A. P., Parreiras‐E‐Silva, L. T., Zanon, N. M., Kettelhut, I. C., & Navegantes, L. C. C.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2011-08-18
- Volume
- 44
- Issue
- 3
- Pages
- 371-381
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2011181550
- Cited by
- 32
- References
- 6
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.